Paper
0
Time of CAR-T Failure Is a Strong Predictor of Outcome for Bispecific Antibody Therapy in Relapsed/Refractory Large B-Cell Lymphoma
Authors
Evgenii Shumilov,Rebecca Wurm‐Kuczera
Vladan Vučinić,Maximilian Seib,Udo Holtick,Paolo Mazzeo,Julia Scholz,Hristo Boyadzhiev,Thomas Melchardt,Alexander Hölscher,Christian Schultze-Florey,Giuliano Velázquez,Anna Saidy,Vadim Lesan,Ulf Schnetzke,Andrea Kerkhoff,Ulrike Bacher,Susanne Ghandili,Enver Aydilek,Niklas Gebauer,Thomas Weber,Gerald Wulf,Bertram Glass,Lorenz Thurner,Florian Heidel,Christoph Schmid,Andreas Viardot,Mathias Hänel,Sascha Dietrich,Thomas Pabst,Francis Ayuk,Bastian Tresckow,Bjoern Chapuy,Christiane Pott,Fabian Mueller,Georg Lenz
+34 authors
,Thomas FischerJournal
Published
Nov 5, 2024
Show more
Save
Tip0
TipSave